Reports
Global Red Biotechnology Market Size, Share, Growth: By Application: Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing; By End-use: Pharmaceutical Industry, CMO & CRO, Research Institutes, Others; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; 2024-2032
Global Red Biotechnology Market Outlook
The global red biotechnology market attained USD 364 billion in 2023 and is expected to grow at a CAGR of 6.20% during the forecast period of 2024-2032 to reach a value of USD 521.2 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is anticipated that the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules will drive the global red biotechnology market.
Market Segmentation
Red biotechnology is a bio-pharmaceutical that involves the utilization of organisms to enhance health care and aid the body in fighting diseases.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global red biotechnology market is segmented into applications and end-uses.
Based on applications, the red biotechnology market can be segmented as:
- Biopharmaceutical Production
- Gene Therapy
- Pharmacogenomics
- Genetic Testing
Based on end-uses, the red biotechnology market can be divided as:
- Pharmaceutical Industry
- CMO and CRO
- Research Institutes
- Others
The EMR report looks into the regional red biotechnology markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Market Analysis
Owing to the increasing demand for gene therapy, clinical research, and trials, the industry for red biotechnology is increasing. People have begun to preserve their stem cells at the moment of birth because of growing awareness, and red biotechnology makes an enormous profit in this segment. The red biotechnology market is aided by the growth of pharmaceutical companies. With the increasing number of patients suffering from cancer globally, red biotechnology applications are becoming common as it helps to understand the cause of the disease, thus, further aiding the growth of the red biotechnology market. The industry is being fuelled by the increased financing in the healthcare industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Competitive Landscape
The report presents a detailed analysis of the following key players in the global red biotechnology industry, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Pfizer Inc. (NYSE: PFE)
- Biogen Inc.
- Amgen Inc.
- AstraZeneca Plc.
- Gilead Sciences, Inc.
- F. Hoffmann-La Roche, Ltd.
- Merck KGaA
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
Key Highlights of the Report:
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Application, End Use, Region |
| Breakup by Application | Biopharmaceutical Production, Gene Therapy, Pharmacogenomics, Genetic Testing |
| Breakup by End Use | Pharmaceutical Industry, CMO & CRO, Research Institutes, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Pfizer Inc. (NYSE: PFE), Biogen Inc. (NASDAQ: BIIB), Amgen Inc. (NASDAQ: AMGN), AstraZeneca Plc. (LON: AZN), Gilead Sciences, Inc. (NASDAQ: GILD), F. Hoffmann-La Roche, Ltd. (SWX: ROG), Merck KGaA (ETR: MRK), Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Red Biotechnology Market Analysis
8.1 Key Industry Highlights
8.2 Global Red Biotechnology Historical Market (2018-2023)
8.3 Global Red Biotechnology Market Forecast (2024-2032)
8.4 Global Red Biotechnology Market by Application
8.4.1 Biopharmaceutical Production
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Gene Therapy
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Pharmacogenomics
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Genetic Testing
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.5 Global Red Biotechnology Market by End-use
8.5.1 Pharmaceutical Industry
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 CMO & CRO
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Research Institutes
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Others
8.6 Global Red Biotechnology Market by Region
8.6.1 North America
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
9 North America Red Biotechnology Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Red Biotechnology Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Red Biotechnology Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Red Biotechnology Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Red Biotechnology Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Pfizer Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Biogen Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Amgen Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Astrazeneca Plc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Gilead Sciences, Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 F. Hoffmann-La Roche, Ltd.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Merck KGaA
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 Bristol-Myers Squibb Company
16.2.8.1 Company Overview
16.2.8.2 Product Portfolio
16.2.8.3 Demographic Reach and Achievements
16.2.8.4 Certifications
16.2.9 Regeneron Pharmaceuticals Inc.
16.2.9.1 Company Overview
16.2.9.2 Product Portfolio
16.2.9.3 Demographic Reach and Achievements
16.2.9.4 Certifications
16.2.10 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Red Biotechnology Market: Key Industry Highlights, 2018 and 2032
2. Global Red Biotechnology Historical Market: Breakup by Application (USD Million), 2018-2023
3. Global Red Biotechnology Market Forecast: Breakup by Application (USD Million), 2024-2032
4. Global Red Biotechnology Historical Market: Breakup by End-use (USD Million), 2018-2023
5. Global Red Biotechnology Market Forecast: Breakup by End-use (USD Million), 2024-2032
6. Global Red Biotechnology Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global Red Biotechnology Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America Red Biotechnology Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe Red Biotechnology Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific Red Biotechnology Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America Red Biotechnology Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa Red Biotechnology Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa Red Biotechnology Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global Red Biotechnology Market Structure
Key Questions Answered in the Report
In 2023, the global red biotechnology market attained a value of nearly USD 364 billion.
The market is projected to grow at a CAGR of 6.20% between 2024 and 2032.
The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach about USD 521.2 billion by 2032.
The major drivers of the market, such as the increasing awareness of chronic illness therapy and a strong pipeline of fresh therapeutic molecules, are expected to aid the market growth.
The key market trend guiding the market growth include the rising investments into the healthcare market.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Biopharmaceutical production, gene therapy, pharmacogenomics, and genetic testing are the leading application segments of the product in the market.
Pharmaceutical market, CMO and CRO, and research institutes, among others, are the significant end-uses of the product in the market.
The major players in the market are Pfizer Inc., Biogen Inc., Amgen Inc., AstraZeneca Plc., Gilead Sciences, Inc., F. Hoffmann-La Roche, Ltd., Merck KGaA, Bristol-Myers Squibb Company, and Regeneron Pharmaceuticals Inc., among others.
Analyst Review
The global red biotechnology market attained a value of USD 364 billion in 2023, driven by the increasing awareness of chronic illness therapy. Aided by the strong pipeline of fresh therapeutic molecules, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 6.20%. The market is projected to reach USD 521.2 billion by 2032.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on applications, the red biotechnology industry can be segmented into biopharmaceutical production, gene therapy, pharmacogenomics, and genetic testing. On the basis of end-use, the industry is divided into pharmaceutical industry, CMO and CRO, research institutes, and others. The major regional markets for red biotechnology are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Biogen Inc., Amgen Inc., AstraZeneca Plc., Gilead Sciences, Inc., F. Hoffmann-La Roche, Ltd., and Merck KGaA, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER